3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
60
Lymphoma
35
Lymphoma, Follicular
31
Lymphoma, Non-Hodgkin
30
Leukemia, Lymphocytic, Chronic, B-Cell
16
Recurrence
11
Lymphoma, Large B-Cell, Diffuse
11
Leukemia
11
Lymphoma, B-Cell
10
Waldenstrom Macroglobulinemia
8
Lymphoma, T-Cell, Cutaneous
8
Hodgkin Disease
8
Mycosis Fungoides
6
Lymphoma, Mantle-Cell
6
Neoplasm, Residual
5
Lymphoma, T-Cell, Peripheral
5
Lymphoma, T-Cell
5
Lymphoma, Extranodal NK-T-Cell
5
Febrile Neutropenia
5
Burkitt Lymphoma
5
Asthma
5
Pain
4
Neoplasms
4
Multiple Myeloma
4
Lymphoma, Large-Cell, Anaplastic
4
Leukemia, Myeloid, Acute
4
Hematologic Diseases
4
Sezary Syndrome
3
Neoplasms, Plasma Cell
3
Myelodysplastic Syndromes
3
Interventions
belimumab
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Sjogren's Syndrome
×
Lymphoid
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled